The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19
1 other identifier
observational
417
1 country
2
Brief Summary
COVID is a major health problem causing massive capacity problems at hospitals. Rapid and accurate diagnostic workflow is of paramount importance. Access to radiological diagnostics tools such as x-ray or computed tomography of the chest are limited even in high-resource settings. Focused lung ultrasound, FLUS, is a point-of-care diagnostic tool that allows rapid and on-site assessment of lung abnormalities. No transportation of the patient is required thus lowering risk of spreading SAR-CoV- inside the hospital. This study aims to explore the diagnostic value of FLUS in the COVID-19 pandemic and to explore if FLUS findings can predict risk of respiratory failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 14, 2020
CompletedFirst Submitted
Initial submission to the registry
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2020
CompletedResults Posted
Study results publicly available
June 10, 2024
CompletedJune 10, 2024
June 1, 2020
3 months
March 27, 2020
January 5, 2022
June 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mechanical Ventilation
Number of patients on mechanical ventilation.
During admission, an average of 1 day
Secondary Outcomes (2)
FLUS Findings and Admission to Intensive Care.
During admission, an average of 1 day
SAR-CoV-2 PCR-test Result.
During admission, an average of 1 day
Eligibility Criteria
All patients who have symptoms on COVID-19 and is seen at a hospital.
You may qualify if:
- Clinical suspicion of COVID-19 requiring contact to a hospital.
You may not qualify if:
- Age less than 18 years
- Previous enrollment in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Lungemedicinsk Forskningsafdeling. Aarhus University Hospital
Aarhus, 8000, Denmark
Regionshospitalet Horsens.
Horsens, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Søren Helbo Skaarup
- Organization
- Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.
Study Officials
- PRINCIPAL INVESTIGATOR
Søren H Skaarup
Aarhus Universitets Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2020
First Posted
March 31, 2020
Study Start
March 14, 2020
Primary Completion
June 15, 2020
Study Completion
June 15, 2020
Last Updated
June 10, 2024
Results First Posted
June 10, 2024
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share